Filing Details
- Accession Number:
- 0000899243-21-024427
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-17 16:33:25
- Reporting Period:
- 2021-06-16
- Accepted Time:
- 2021-06-17 16:33:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651431 | Checkmate Pharmaceuticals Inc. | CMPI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1335659 | M Arthur Krieg | C/O Checkmate Pharmaceuticals, Inc. 245 Main Street, 2Nd Floor Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-16 | 3,578 | $6.18 | 808,510 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions, at prices ranging from $6.17 to $6.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Billionaire Hedge Funds
